167 related articles for article (PubMed ID: 3964332)
1. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
[TBL] [Abstract][Full Text] [Related]
2. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
[TBL] [Abstract][Full Text] [Related]
3. [Bioavailability of new nifedipine preparations in man. 2. Bioequivalence of nifedipine in the form of soft gelatin capsules].
Dahmen W; Pabst G; Molz KH; Lutz D; Jaeger H
Arzneimittelforschung; 1985; 35(12):1842-4. PubMed ID: 4096742
[TBL] [Abstract][Full Text] [Related]
4. [Biotransformation and bioequivalence of a new nifedipine preparation].
Achtert G; Wisotzki R; Lutz D; Jaeger H
Arzneimittelforschung; 1987 Nov; 37(11):1296-7. PubMed ID: 3440039
[TBL] [Abstract][Full Text] [Related]
5. [A model study of bioequivalence of dissolved nifedipine from soft gelatin capsules].
Menke G; Kausch M; Rietbrock N
Arzneimittelforschung; 1988 Feb; 38(2):300-4. PubMed ID: 3370080
[TBL] [Abstract][Full Text] [Related]
6. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
[TBL] [Abstract][Full Text] [Related]
7. [The bioequivalence of two nifedipine fluid capsules].
Thürmann P; Bacracheva N
Arzneimittelforschung; 1989 Dec; 39(12):1597-9. PubMed ID: 2624612
[TBL] [Abstract][Full Text] [Related]
8. [Bioequivalence of nifedipine sustained-release formulations in comparison to standard preparations in solid state].
Herrmann R
Arzneimittelforschung; 1996 Jan; 46(1):28-34. PubMed ID: 8821514
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
[TBL] [Abstract][Full Text] [Related]
10. Relative bioavailability of carbinoxamine and phenylephrine from a retard capsule after single and repeated dose administration in healthy subjects.
Stockis A; Deroubaix X; Jeanbaptiste B; Lins R; Allemon AM; Laufen H
Arzneimittelforschung; 1995 Sep; 45(9):1009-12. PubMed ID: 7488301
[TBL] [Abstract][Full Text] [Related]
11. [Bioavailability and pharmacokinetics of a new nifedipine preparation in healthy volunteers].
Hutt V; Molz KH; Pabst G; Dilger C; Mosberg H; Jaeger H
Arzneimittelforschung; 1989 May; 39(5):607-11. PubMed ID: 2757680
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
13. Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers.
Balogh Nemes K; Horváth V; Grézal G; Horvai G; Hrabéczy-Páll A; Kocsi E; Drabant S; Csörgö M; Renczes G; Klebovich I
Int J Clin Pharmacol Ther; 1998 May; 36(5):263-9. PubMed ID: 9629990
[TBL] [Abstract][Full Text] [Related]
14. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers.
Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R
Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014
[TBL] [Abstract][Full Text] [Related]
17. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state].
Meyer FP; Banditt P
Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers.
Bohner H; Janiak PS; Nitsche V; Eichinger A; Schütz H
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):117-22. PubMed ID: 9089001
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]